Found 23 matching trials
To Evaluate the Efficacy, Safety, and Tolerability of BBT-877 in Patients With IPF PHASE2 This is a Phase 2, multicenter, randomized, double-blind, placebo-controlle...
Show More Location
Pulmonary Associates P.A.
Learn More & Join Trial
To Evaluate Drug-drug Interactions Between HEC585 and Pirfenidone or Nintedanib in Healthy Volunteers PHASE1 An open label study to evaluate drug-drug interactions between HEC585 and P...
Show More Location
Shanghai Xuhui Central Hospital
Learn More & Join Trial
To Evaluate Drug-drug Interactions Between DWN12088 and Pirfenidone or Nintedanib in Healthy Volunteers PHASE1 An open label, 2-part, one-sequence, 3-period study to evaluate drug-drug i...
Show More Location
Cha Unitersity Bundang Medical Center
Learn More & Join Trial
Management of Progressive Disease in Idiopathic Pulmonary Fibrosis PHASE4 Idiopathic pulmonary fibrosis (IPF) is a prototype of chronic, progressive,...
Show More Learn More & Join Trial
A Study of the Pharmacokinetic Interaction Between Pirfenidone, Nintedanib, and Nalbuphine Extended Release (NAL ER) in Healthy Participants PHASE1 The primary purpose of this study is to evaluate the effect of steady-state...
Show More Location
Clinical Pharmacology of Miami
Learn More & Join Trial
Intravenous Immunoglobulin for the Treatment of Acute Exacerbations of Idiopathic Pulmonary Fibrosis PHASE3 Acute exacerbations of idiopathic pulmonary fibrosis (AE-IPF) are sudden an...
Show More Location
Department of Respiratory Medicine, University Hospital of Patras
Learn More & Join Trial
A Study to Test How Taking BI 1015550 for 12 Weeks Affects Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) PHASE2 This study is open to adults with idiopathic pulmonary fibrosis (IPF) who a...
Show More Location
St. Francis Medical Institute
Learn More & Join Trial
Study of Oral Epigallocatechin-3-gallate (EGCG) in IPF Patients PHASE1 The primary purpose of this multi-center, double-blind, placebo-controlled,...
Show More Learn More & Join Trial
A Study to Evaluate Pharmacokinetics and Drug-drug Interactions of ENV-101 (Taladegib) in Healthy Participants PHASE1 The purposes of this study are to:
1. evaluate potential interactions betw...
Show More Learn More & Join Trial
A Study Based on Medical Records That Looks at the Characteristics of Idiopathic Pulmonary Fibrosis Patients Grouped by the Type of Medication They Are Taking N/A To understand differences in characteristics of Idiopathic Pulmonary Fibros...
Show More Learn More & Join Trial